Description
ARA-290 (cibinetide) is a synthetic, 11-amino acid peptide derived from erythropoietin (EPO) that acts as a potent anti-inflammatory and tissue-repairing agent without stimulating red blood cell production. It primarily treats neuropathic pain and chronic inflammation by binding to the Innate Repair Receptor (IRR).
Key Benefits of ARA-290:
- Neuropathic Pain Relief: Effectively reduces chronic pain associated with small fiber neuropathy and sarcoidosis.
- Nerve Repair: Promotes regeneration of small nerve fibers (e.g., corneal nerve fiber density).
- Anti-Inflammatory: Suppresses pro-inflammatory cytokines like TNF-α𝛼, IL-1β𝛽, and IL-6.
- Diabetic Neuropathy Management: Improves metabolic control and reduces diabetic neuropathic symptoms.
- Tissue Protection: Protects against ischemic injury, hypoxia, and oxidative stress.
Administration:
- It is typically self-administered, with improvements in symptoms often observed within 2–4 weeks.
- Research often investigates specific, sometimes higher, dosage protocols to evaluate efficacy in neuropathic pain management.
Disclaimer: This information is for educational purposes based on research studies and does not constitute medical advice. Consult a healthcare provider before starting any peptide therapy.
Reviews
There are no reviews yet.